Results 181 to 190 of about 6,956,776 (231)

Design and validation of a key performance indicator dashboard for equity in community and retail pharmacy services in Pakistan. [PDF]

PLoS One
Hammad M, Arif R, Khan AZ, Nasir A.
europepmc   +1 more source

Enhancing Evidence Generation by Linking Randomized Clinical Trials to Real‐World Data: The INVESTED‐Medicare Linkage Study

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world evidence (RWE) derived from real‐world data (RWD) can complement randomized controlled trials (RCTs), yet the validity of RWD relative to RCT data remains insufficiently characterized. We obtained post hoc consent and linked individual participant data from the US‐based INVESTED trial (2016–2019) with Medicare fee‐for‐service claims (2012 ...
Hanseul Cho, HoJin Shin, Mehdi Najafzadeh, Brian Claggett, Janinne Ortega‐Montiel, Jun Liu, Julie M. Paik, Narlina F. Lalani, Marie C. Bradley, John Concato, Scott D. Solomon, Orly Vardeny, Elisabetta Patorno   +12 more
wiley   +1 more source

Infection-embedded penicillin allergy de-labelling delivers immediate antimicrobial stewardship gains in patients with active infection. [PDF]

JAC Antimicrob Resist
Harris S, Luintel A, Jones S, Hardy-Gould G, Reynolds N, Panesar P, Makatsori M, Lukawska J, Balakrishnan I, Kew A, Watson C, McGregor A, Gant V, Patel T, Das A.   +14 more
europepmc   +1 more source

Dispensing of actionable pharmacogenetic drugs among adults receiving cardiovascular disease medications in the Northern Netherlands: A serial cross‐sectional study

Clinical Pharmacology &Therapeutics, EarlyView.
The extent of pharmacogenetic (PGx) drug dispensing among Dutch adults receiving medications for cardiovascular disease (CVD) is unknown. Using the University of Groningen IADB.nl pharmacy database, we performed a serial cross‐sectional study (2019–2023) to estimate the annual prevalence of PGx drug dispensing and annual rates of initiation.
Zhuolin Zhang, Guiling Zhou, Jens H. J. Bos, Eelko Hak, Talitha Feenstra, Frank Klont   +5 more
wiley   +1 more source

Accessibility to medical institutions in Aichi Prefecture: A geographic information systems-based analysis. [PDF]

PLoS One
Ito S, Yamazaki T, Sugishita K, Kageyama K, Sato M, Fujita M, Nakao S, Ichihara N, Nokura Y, Yamashita M, Hattori R, Tamaki H, Ino Y, Iguchi K, Nakamura M.   +14 more
europepmc   +1 more source

Toward Fit‐for‐Purpose Data for Drug Assessment in Non‐small Cell Lung Cancer: A Core Dataset

Clinical Pharmacology &Therapeutics, EarlyView.
Considering the high unmet medical need in people with non‐small cell lung cancer (NSCLC), the drug assessment for targeted therapies often rely on small populations and single‐arm trials, challenging the evaluation by regulatory authorities, health technology assessment bodies (HTAb), and clinicians.
Geeske F. Grit, Maaike van Dartel, Laura Rodwell, Hanneke van der Woude, Cornelis Boersma, Peter G. M. Mol, Doranne Hilarius   +6 more
wiley   +1 more source

Beyond Pharmacokinetics: Gaps for Rational Use of Medicinal Cannabis. [PDF]

J Clin Pharmacol
Lu S, Liu X, Truong L, Liu Z, Guo F, Martin J, Zhu X.   +6 more
europepmc   +1 more source

Relational Capital and Sustainable Development in Developing Economies: A Systematic Review of Pathways, Practises and Impacts

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study critically examines the role of relational capital (RC) in shaping the sustainable development of small and medium‐sized enterprises (SMEs). Although RC is widely recognised as a strategic resource, existing evidence remains fragmented, context‐dependent and theoretically underdeveloped.
Rana Kayyal, Ali Meftah Gerged
wiley   +1 more source